Literature DB >> 15776916

[Management of radiation cystitis].

Jérôme Rigaud1, Jean-François Hetet, Olivier Bouchot.   

Abstract

Radiation cystitis is a lesion of the bladder caused by irradiation of a pelvic organ. These lesions can range from a simple inflammatory reaction to almost complete bladder retraction. The frequency of chronic lesions is estimated to be between 5% and 10% of patients receiving pelvic radiotherapy. Radiation cystitis generally presents in the form of macroscopic haematuria associated with frequency and urgency. The diagnosis is often easy due to the patient's history of pelvic irradiation. Cystoscopy demonstrates a pale, frosted bladder mucosa with scattered telangiectasias and sometimes well defined torpid ulcerations. The treatment of radiation cystitis is essentially symptomatic, mainly consisting of controlling the episodes of haematuria by bladder lavage. Several more or less specific treatments have been proposed in order to decrease the episodes of haematuria. The treatments most frequently used are intravesical instillations of formalin, silver nitrate or alum with an efficacy on symptoms of about 70%. Another more recent and very encouraging treatment option is hyperbaric oxygen therapy, which allows better tissue diffusion of oxygen, improving neo-angiogenesis by increasing the vascular density of irradiated tissues. This technique is effective in about 80% to 90% of cases with a lasting effect. It also allows objective improvement of the bladder mucosa. Finally, in severe cases of persistent haematuria, arterial embolization or even cystectomy with urinary diversion may be proposed.

Entities:  

Mesh:

Year:  2004        PMID: 15776916

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  7 in total

Review 1.  A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis.

Authors:  Xavier Liem; Fred Saad; Guila Delouya
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

2.  Interventions to treat hemorrhagic cystitis: a systematic review and meta-analysis.

Authors:  Claudia Milena Pitto; Herney Andrés García-Perdomo
Journal:  Support Care Cancer       Date:  2017-05-01       Impact factor: 3.603

3.  Superselective embolisation of bilateral superior vesical arteries for management of intractable hematuria in context of metastatic bladder cancer.

Authors:  Ahmed Saadi; Abderrazak Bouzouita; Mohamed Hedi Rebai; Mohamed Cherif; Walid Kerkeni; Haroun Ayed; Amine Derouiche; Hatem Rajhi; Riadh Ben Slama; Najla Mnif; Mohamed Chebil
Journal:  Asian J Urol       Date:  2016-05-01

Review 4.  Chronic Inflammation and Radiation-Induced Cystitis: Molecular Background and Therapeutic Perspectives.

Authors:  Carole Helissey; Sophie Cavallero; Clément Brossard; Marie Dusaud; Cyrus Chargari; Sabine François
Journal:  Cells       Date:  2020-12-24       Impact factor: 6.600

Review 5.  Understanding Molecular Mechanisms and Identifying Key Processes in Chronic Radiation Cystitis.

Authors:  Clément Brossard; Anne-Charlotte Lefranc; Jean-Marc Simon; Marc Benderitter; Fabien Milliat; Alain Chapel
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 6.  Molecular Mechanisms and Key Processes in Interstitial, Hemorrhagic and Radiation Cystitis.

Authors:  Clément Brossard; Anne-Charlotte Lefranc; Anne-Laure Pouliet; Jean-Marc Simon; Marc Benderitter; Fabien Milliat; Alain Chapel
Journal:  Biology (Basel)       Date:  2022-06-28

7.  Two New Potential Therapeutic Approaches in Radiation Cystitis Derived from Mesenchymal Stem Cells: Extracellular Vesicles and Conditioned Medium.

Authors:  Carole Helissey; Nathalie Guitard; Hélène Théry; Sylvie Goulinet; Philippe Mauduit; Maria Girleanu; Anne-Laure Favier; Michel Drouet; Charles Parnot; Cyrus Chargari; Sophie Cavallero; Sabine François
Journal:  Biology (Basel)       Date:  2022-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.